Literature DB >> 4749404

Hypoglycemic action of fenfluramine in diabetes mellitus.

J R Turtle, J A Burgess.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4749404     DOI: 10.2337/diab.22.11.858

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  8 in total

1.  Dose related effect of fenfluramine and norfenfluramine on glucose uptake into human isolated skeletal muscle.

Authors:  M J Kirby
Journal:  Br J Clin Pharmacol       Date:  1974-12       Impact factor: 4.335

Review 2.  The chronic cardiovascular risk factor syndrome (syndrome X): mechanisms and implications for atherogenesis.

Authors:  S C Bain; P M Dodson
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

3.  Metabolic effects of fenfluramine in obese diabetics.

Authors:  S Larsen; L Vejtorp; P Hornnes; H Bechgaard; L Sestoft; J Lyngsoe
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

Review 4.  Anorectic drugs: use in general practice.

Authors:  D Craddock
Journal:  Drugs       Date:  1976       Impact factor: 9.546

Review 5.  Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity.

Authors:  R M Pinder; R N Brogden; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

6.  Pulmonary hypertension and fenfluramine.

Authors:  J G Douglas; J F Munro; A H Kitchin; A L Muir; A T Proudfoot
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-03

7.  The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia.

Authors:  Nicole M Sanders; Charles W Wilkinson; Gerald J Taborsky; Salwa Al-Noori; Wendi Daumen; Aryana Zavosh; Dianne P Figlewicz
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-03-11       Impact factor: 4.310

8.  Sucrose intake unaffected by fenfluramine but suppressed by amphetamine administration.

Authors:  N Orthen-Gambill
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.